Cargando…
Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer death in many Asian and African countries. Lack of early diagnosis tools is one of the clinical obstacles for effective treatment of HCC. Thus, enhanced understanding of the molecular changes associated with HCC is urgently needed to develo...
Autores principales: | Xie, Hui, Ma, Hongwei, Zhou, Danqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674644/ https://www.ncbi.nlm.nih.gov/pubmed/23762823 http://dx.doi.org/10.1155/2013/136106 |
Ejemplares similares
-
Long noncoding RNA HULC promotes hepatocellular carcinoma progression
por: Zhang, Hongwei, et al.
Publicado: (2019) -
Long noncoding RNA HULC regulates the NF‐κB pathway and represents a promising prognostic biomarker in liver cancer
por: Liu, Shihai, et al.
Publicado: (2022) -
Interference of miR‐107 with Atg12 is inhibited by HULC to promote metastasis of hepatocellular carcinoma
por: Zhang, Haiming, et al.
Publicado: (2020) -
Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer
por: Jin, Chunjing, et al.
Publicado: (2016) -
Correction to: Interference of miR‐107 with Atg12 is inhibited by HULC to promote metastasis of hepatocellular carcinoma
Publicado: (2023)